Dyslipidemia observed in type 2 diabetes mellitus (T2DM) is characterized by elevated triglycerides, ApoB, and small dense low-density lipoprotein (sd-LDL) levels, along with a concurrent decrease in HDL-C, all stemming from the underlying insulin resistance. This evidence concerns the gene APOB and type 2 diabetes mellitus.